Fact CheckerSign in

NCT06726187Recruiting

DSM-5 Personality Disorders in Adults With Autism

Source: ClinicalTrials.gov · Last updated 17 Jul 2026

Brief summary (registry, in English)

Rationale: Self-report measures are frequently used for research and clinical assessments of adults with autism spectrum disorder (ASD). However, there has been little research examining agreement between self-report and informant-report in this population. Reliable self-report measures are essential for conducting research with and providing high quality clinical services for adults with autism spectrum disorder. Objective: This study aims to examine the usefulness of self-report of DSM-5-TR PD traits in adults with ASD compared to informant-reports by administering the self-report screening measure of the Structured Clinical Interview for DSM-5 Screening Personality Questionnaire (SCID-5-SPQ).

Status (registry)
Recruiting
Study type
Observational
Enrollment
102 (estimated)
First submitted
5 Dec 2024
Start date
1 Mar 2024
Primary completion date
28 Jan 2027
Lead sponsor
Parnassia Groep
Diseases
Autism
NCT number
NCT06726187

What you commit to

  • Study type: Observational
  • Planned participants: 102
  • From 1 Mar 2024 to the primary completion date, 28 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Participants were asked to identify individuals who knew them well and were capable of providing accurate descriptions of their personality traits, preferably informants that cohabited with the participants. When cohabitants were unavailable, participants were asked to identify "the person who knows you best." Additionally, eligibility of informants for inclusion required that, historically, the informant and the participant talked at least monthly and interacted face-to-face at least yearly.

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sarr - Parnassia Groep Antes
Coordinator of this site? Confirm its status
RotterdamNetherlandsRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.